AT-10

Anti-platelet / Cardiovascular

Phase IActive

Key Facts

Indication
Anti-platelet / Cardiovascular
Phase
Phase I
Status
Active
Company

About Ipca Laboratories

Ipca Laboratories is a mission-driven, fully integrated global pharmaceutical company dedicated to advancing healthcare through quality, affordable medicines. Its strategic achievements include establishing world-leading API manufacturing capabilities, securing approvals from stringent global regulators, and building a robust international footprint. The company's core strategy hinges on vertical integration for cost and supply chain control, therapeutic area dominance, and a growing R&D focus on novel drugs and biologics to drive future growth.

View full company profile